Xiang J. Meng
Xiang J. Meng is a Professor of molecular virology at Virginia Polytechnic Institute and State University (Blacksburg, Virginia). Meng received his Ph.D. degree in immunobiology from Iowa State University College of Veterinary Medicine in Ames, Iowa, USA. Prior to joining the faculty at Virginia Tech in 1999, Meng was a senior staff scientist at the National Institute of Allergy and Infections Diseases at NIH in Bethesda, Md, USA. His research focuses on molecular mechanisms of viral pathogenesis and vaccine developments against emerging and zoonotic viruses of human and veterinary public health significance. The viruses being studied in the Meng Laboratory include swine, avian, and human hepatitis E viruses, porcine circoviruses, porcine reproductive and respiratory syndrome virus, and swine TT viruses. Dr. Meng has published more than 190 peer-reviewed scientific papers, reviews, and book chapters, and he is an inventor for more than 20 awarded patents on virus vaccines and diagnostics. Dr. Meng is the lead inventor of the first USDA fully licensed vaccine, Suvaxyn PCV2 One Dose, against the circovirus (currently marketed by Pfizer Inc.). Dr. Meng has served on the Editorial Boards for 7 international journals and as members or chairs on numerous federal review panels including permanent Member of the NIH DDR Study Section and permanent Member of the NIH Virology-A Study Section. Dr. Meng has served as officers for numerous international and national organizations and committees such as the Chairman of Hepeviridae Study Group of the International Committee on Taxonomy of Viruses, Chair of the NIH Special Emphasis Panel IDM-B (15), Chair for the 2010-2011 International PRRS Symposia, and Chair of the USDA NC-229 Committee on PRRS and Respiratory Diseases.
Biography Updated on 16 January 2011